Genomic Medicine in 3D
Genomic Medicine in 3D
Sanofi Norway
Sanofi is a global pharmaceutical company with more than 90,000 employees in over 100 countries. At Sanofi, we are driven by a shared purpose and ambition. We believe that our pioneering research in science and development, fuelled by data and digital technology, has the potential to transform the practice of medicine and to make the impossible possible for millions of people around the world.
At Sanofi, we chase the miracles of science to improve people's lives.
Scientific breakthroughs don't happen overnight, but require hard work. Our clear desire to help patients motivates us to develop breakthrough medicines and vaccines - we never give up.
From our beginnings as a local French company to today, where we are a global leader in the pharmaceutical industry, innovation has been part of our DNA. We are constantly searching for solutions that can improve the lives of patients, partners, communities and our own employees.
Sanofi has its global headquarters in Paris, France. In Norway, the office is located in Lysaker with approximately 80 employees.
Our therapeutic areas
Diabetes and cardiovascular diseases
Conversation app for diabetes patients and carers
The FuelBox app is a conversation app with thousands of questions to kickstart the good, the difficult and the fun conversations.
Immunology
Are you living with atopic eczema, asthma or nasal polyps?
If you are living with an atopic disease such as atopic dermatitis (atopic eczema), asthma or nasal polyps, please visit our patient website atopiker.no, which is full of relevant information and support for those living with these diseases.
Neurology
Are you living with multiple sclerosis (MS)?
If you are living with multiple sclerosis (MS), please visit our patient website ms-guiden.no, which is full of relevant information and support for those living with MS.
Work with us
Forbes named us the second best employer in our industry in 2022. Start your career with us today.
Discover new opportunities
Reporting of value transfers
Collaboration between the pharmaceutical industry and healthcare professionals benefits patients. This collaboration has resulted in many innovative medicines and has changed the way many diseases affect our lives.1
EFPIA
EFPIA reporting
Sanofi is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and follows the EFPIA Disclosure code. This means that we report transfers of value made to healthcare professionals and healthcare organisations. The EFPIA Disclosure code has been implemented by the pharmaceutical industry itself to ensure that pharmaceutical companies proactively report all payments to healthcare professionals and healthcare organisations in an open and transparent manner. An example of value transfer could be a fee to a healthcare professional for participation in an expert group meeting or as a speaker at a conference.
Sanofi's value transfers to healthcare professionals and healthcare organisations
Support for patient organisations
Sanofi's support to patient organisations for the previous year is shown in the table below.
The Transparency Act
Following the introduction of the Transparency Act on 1 July 2022, both Sanofi AS and other companies are now obliged to be more open and transparent about the impact our business has on the society around us. The purpose of the Transparency Act is to reduce the risk of companies causing or contributing to human rights violations. This law requires us to take responsibility and ensure decent working conditions for our suppliers, owners and ourselves.
Sanofi AS has a clear intention to maintain integrity in all our business activities, and we place great emphasis on ensuring basic human rights and decent working conditions for our employees and suppliers. We take our responsibility seriously and are committed to complying with the Transparency Act.
This is Sanofi AS's statement on managing the risk of human rights and decent labour conditions violations in our supply chain.
Coping with serious illness - Watch the recording of our live broadcast on Facebook
What happens when someone becomes seriously ill and how do you cope with life with a serious diagnosis?
On 7 April, we marked World Health Day with a live broadcast on Facebook, where we highlighted questions about how to cope with living with a serious diagnosis. We brought together experts and people with experience in the field to talk about how to deal with such a situation.
Watch the recording.
How should I proceed?
Suspicion of a serious illness can easily cause stress and uncertainty. When a diagnosis is finally confirmed, it's natural to react emotionally. Even if you had suspicions beforehand, the emotions can still be strong.
This brochure is intended as a guide for people who are ill and their relatives. The brochure is designed for adults and provides advice on how to move forward even with a serious illness.
How to talk to children about illness in the family
Serious illness, whether acute or chronic, affects not only the person who is ill, but also the whole family, especially those closest to you. Children are often in a particularly vulnerable situation because they do not have the same ability as adults to cope with sudden and difficult changes.
Life can present situations that you are not necessarily prepared for, and things don't always turn out the way you hope. When a family experiences illness, children and young people need support in this demanding situation, as well as room for growth and development.
Feeling anxious?
Your feelings are understandable and common. The purpose of this leaflet is to provide help and tips to help you feel better.
It is possible to stop this chain reaction that can lead to fear or panic. This is a skill that you can acquire by practising.